Wakefield Asset Management’s Merit Medical Systems MMSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-9,820
Closed -$821K 163
2023
Q2
$821K Sell
9,820
-1,695
-15% -$138K 0.33% 85
2023
Q1
$852K Sell
11,515
-5
-0% -$351 0.35% 74
2022
Q4
$814K Sell
11,520
-3
-0% -$200 0.34% 82
2022
Q3
$651K Buy
11,523
+12
+0.1% +$691 0.3% 105
2022
Q2
$625K Buy
11,511
+38
+0.3% +$2.32K 0.27% 109
2022
Q1
$763K Sell
11,473
-73
-0.6% -$4.39K 0.27% 117
2021
Q4
$719K Buy
11,546
+105
+0.9% +$7.04K 0.25% 128
2021
Q3
$821K Sell
11,441
-278
-2% -$18.9K 0.31% 91
2021
Q2
$758K Buy
11,719
+25
+0.2% +$1.55K 0.29% 111
2021
Q1
$700K Sell
11,694
-469
-4% -$26.9K 0.28% 119
2020
Q4
$675K Buy
+12,163
New +$628K 0.28% 104

Other funds holding MMSI

Wakefield Asset Management's MMSI Position: Q3 2023 in Review

Wakefield Asset Management sold out of Merit Medical Systems (MMSI) in Q3 2023, closing a stake of 9,820 shares — an estimated $821K sold.

Wakefield Asset Management first reported a position in MMSI in Q4 2020 and held it in 11 quarters. The position peaked at $852K in Q1 2023. 272 funds tracked by Wall St. Rank hold MMSI as of Q3 2023.

  • Wakefield Asset Management reported no remaining Merit Medical Systems position as of Q3 2023 after selling out during the quarter.
  • Wakefield Asset Management sold 9,820 Merit Medical Systems shares in Q3 2023, an estimated $821K.
  • Wakefield Asset Management first reported a position in Merit Medical Systems in Q4 2020 and held it in 11 quarters.
  • Wakefield Asset Management's Merit Medical Systems position peaked at $852K in Q1 2023.
  • 272 funds tracked by Wall St. Rank held Merit Medical Systems as of Q3 2023.

Based on Wakefield Asset Management's 13F filing for Q3 2023, filed 1 Nov 2023.